• 대한기관식도과학회지
• /
• 제4권2호
• /
• pp.188-192
• /
• 1998

Background and Objectives： The most common cause of the failure of endoscopic dacryocystorhinostomy is closure of the osteotomy site due to granulation or adhesion. We used mitomycin-C, an antineoplastic antibiotic agent, soaking over the osteotomy site to suppress fibrous proliferation and scar formation during the endoscopic dacryocystorhinostomy. Materials and Methods : A total of 20 Patients diagnosed with nasolacrimal duct obstruction were assigned randomly to either a mitomycin-C group or a control group. Endoscopic dacryocystochinostnmy has been used in both groups. In the mitomycin-C group, a piece of merocel soaked with 0.2 mg/ml mitomycin-C was applied to the osteotomy site and then after 30 minutes was removed. Results : All patients in the mitomycin-C group remained symptom free after removal of their silicone tube (100% success), and there were two patients in the control group who had recurrent epiphora (67% success). In the mitomycin-C group, the average surface area of the osteotomy at the end of the sixth postoperative month was 4.1 $\textrm{mm}^2$, whereas that of the control group was 2.5 $\textrm{mm}^2$. Neither serious systemic nor local toxicity were noted in the mitomycin-C group. Conclusion : Intraoperative mitomycin-C may possibly improve success rates over the endoscopic dacryocystorhinostomy procedure.

• 한국임상수의학회지
• /
• 제23권2호
• /
• pp.153-157
• /
• 2006

The purpose of this study was to determine the effects of mitomycin C on conjunctival fibroblast proliferation and apoptosis. Rabbit conjunctival fibroblast mono layers were treated with 48 hours application of mitomycin-C. The viability of cells was evauated by MTT assay. To examine the effect of mitomycin-C on the cell proliferation, immunocytochemistry for BrdU staning was performed. Then, we investigated whether mitomycin-C induced cell's apoptosis by TUNEL staining. As a result of MTT assay, the viability of cells was gradually inhibited in a dose dependent manner by mitomycin-C. The BrdU staining showed that mitomycin-C significantly suppressed the proliferation of conjunctival fibroblast at concentrations of 0.02% or more. When TUNEL assays were performed, the number of apoptotic cells increased 5.6-, 18.5-, and 33.8-fold compared with the control at 0.01, 0.02, and 0.04%, respectively, of mitomycin-C at 48 hours of exposure. Therefore, mitomycin-C may be useful as a regulator in the treatment of corneal diseases that manifest with scar formation and tumor of fibroblast expansion.

• 한국동물학회지
• /
• 제16권4호
• /
• pp.211-217
• /
• 1973

Streptomyces caespitosus에서 分離된 抗生物質인 Mitomycin C를 Chinese hamster, Cricetulus griseus (2n=22) euploid 細胞朱인 22Emb. (♀, 20일된 embryo에서 培養한 것)과 5PSP (♂, polyoma transformed subclone)에 分量과 時間을 달리해서 處理했을 경우 일어나게 되는 特異한 染色體 異常을 觀察하였다. Mitomycin C의 分量과 處理時間 그리고 細胞朱에 따라서 染色體에 미치는 影響이 한결같지 않지만 第1, 第2 染色體의 region 5와 7, 그리고 X 染色體의 第2 收縮環(secondary constriction)에 보다 甚한 染色體 切斷을 보여 주었다. 이것은 Mitomycin C가 特히 染色體의 人形成體(nucleolar-organizar)에 關聯되어 일어나는 現象이 아닌가 생각된다.

• Applied Biological Chemistry
• /
• 제39권6호
• /
• pp.424-429
• /
• 1996

유색미 쌀겨가 화학적 변이원에 의한 유전독성을 억제하는 작용기작을 유색미 품종인 수원415호 쌀겨의 유기용매추출물과 변이원인 mitomycin C를 이용하여 조사하였다. 70%에탄올 분획 및 클로로포름분획에서 수원 415호는 대조구로 사용된 추청에 비하여 변이원에 대한 억제활성이 월등히 높았음에도 불구하고 항산화활성은 추청보다 다소 낮은 결과로 보아 항산화작용과는 다른 억제기작이 존재함을 추정할 수 있었다. E. coli를 지시세포로 유색미 쌀겨 추출물의 mitomycin C에 대한 변이원성 억제기작을 조사한 결과, desmutagen으로 작용할 가능성이 크다는 사실을 알았고, 쌀겨 추출물과 mitomycin C를 반응시킨 후 반응액 중에 존재하는 유리상태의 mitomycin C를 정량한 결과, 유색미의 쌀겨 추출물이 mitomycin C에 직접 결합하여 변이원을 흡착함으로써 세포에 대한 유전독성을 억제할 것으로 생각되었다.

• 한국환경보건학회지
• /
• 제18권2호
• /
• pp.117-124
• /
• 1992

Pretreatment with low concentration of Bleomycin and Cadmium rendered Chinese Hamster Ovary Cells more resistant to the induction of chromosome aberration by subsequent high concentration of same agent, however Mitomycin C did not function in that way. The cells pre-exposed to low dose of Cadmitim did not show cross-resistance to challenge dose of Mitomycin C for the induction of chromosome aberration, but cells pre-exposed to Bleomycin showed cross resistance. And the cells pre-exposed to low dose of Mitomycin C showed cross resistance to challenge of Bleomycin, but Cadmium did not.

• 생약학회지
• /
• 제23권2호
• /
• pp.89-95
• /
• 1992

The water extract of Gamidaebo-Tang depressed the lethal toxicity of cis-platin$(45{\mu}M/kg,\;s.c.)$, and mitomycin C (6mg/kg, s.c.). Significant depression of renal toxicity(indicated by an increased blood urea nitrogen value and creatinine value) of cis-platin $(35{\mu}M/kg)\;s.c.)$, was observed in mice treated with Gamidaebo-Tang. In rats treated with mitomycin C and Gamidaebo-Tang, the increased LDH activity and reduced total protein and albumin contents by mitomycin C were significantly depressed. The number of WBC was significantly increased in rats treated with mitomycin C but in the rats treated with mitomycin C and Gamidaebo-Tang, the number of WBC was increased and the hematocrit value and the number of RBC and Hgb were significantly increased in the dose-dependent manner. Therefore, bone marrow toxicity of mitomycin C in the rats treated with Gamidaebo-Tang was depressed. In the end, alleviative effects of the side actions of cis-platin and mitomycin C were acknowledged by combined usage of Gamidaebo-Tang and these anti-neoplastic drugs.

• Applied Microscopy
• /
• 제29권1호
• /
• pp.25-41
• /
• 1999

종양의 치료제로 많이 사용되고 있는 대표적인 항암제 가운데 대사길항제인 5-fluorouracil과 항암항생제인 mitomycin C가 콩팥토리에 미치는 영향을 미세구조적으로 비교 관찰하고자 이 실험을 시행하였다. Mitomycin C는 $LD_{50}$의 1/20 이하인 $400{\mu}g/kg$를, 5-fluorouracil는 $LD_{50}$의 1/4 정도인 60mg/kg를 격일 간격으로 계속 투여하였다. 각 항암제투여군은 처음 주사후 4일 (2회 투여)과 7일 (3회 투여) 째에 희생시킨 후 콩괄겉질부위의 조직을 메어 JEM 100CX-II 전자 현미경으로 관찰하였다. 1. 5-fluorouracil 및 mitomycin C 투여후 4일군에서는 다같이 혈관사이막이 증가하여 모세혈관과 주머니공간이 매우 좁아 보이는 부분이 많았는데, 그 현상은 mitomycin C 투여군에서 더 심했다. 2. 5-fluorouracil 투여 7일군은 토리의 미세구조가 거의 정상군의 모습과 비슷하게 회복되어 보였으나 mitomycin C 투여 7일군은 토리의 미세구조가 정상군의 모습과 비슷하게 회복된 모습을 거의 관찰할 수 없었다. 3. Mitomycin C 투여 4일군과 7일군에서는 내피세포의 종창현상(swelling) 이 심해서 내강으로 돌출되었을 뿐만 아니라 혈관사이세포가 모세혈관내강으로 돌출되어 내강을 거의 막고 있는 경우가 자주 관찰되었다. 4. Mitomycin C 투여 4일군에서는 토리모세혈관바닥막의 속투명판과 바깥투명판의 전자밀도가 높아서 치밀판과의 경계가 뚜렷하지 못한 부분이 많았는데, 부위에 따라서는 속투명판이 넓어진 부분이 관찰되기도 하였다. 이상의 결과를 종합해 보면 mitomycin C를 투여하였을 경우에는 마우스의 콩팥토리는 모세혈관의 내강이 좁아지고 혈관사이막이 증가하며 내피세포는 종창현상을 보이는 등의 미세구조적 변화를 보였다. 그러나 5-fluorouracil을 투여하였을 경우, 초기 (4일)에는 발세포와 혈관사이막의 경우 mitomycin C 투여군에서와 비슷한 미세구조적 변화를 보였으나, 7일군에서는 거의 정상군의 소견과 비슷한 모습을 보였다. 이와 같은 결과는 콩팥토리를 비롯한 콩팥조직에 미치는 세포독성은 mitomycin C가 5-fluorouracil에 비하여 훨씬 더 강하기 때문이라고 생각된다.

• Clinical and Experimental Pediatrics
• /
• 제62권10호
• /
• pp.395-399
• /
• 2019

Background: The esophagus is the most common part of gastrointestinal (GI) tract at the risk of stricture. Benign disorders are the leading causes of narrowing. Caustic ingestion is the most common cause of esophageal stricture in children, especially in developing countries. Clinical responses to the topical application of Mitomycin C in various medical procedures have been reported. Purpose: The study aimed to evaluate the methodology, efficacy, and side effects of Mitomycin C in the treatment of esophageal strictures. Methods: This study included 30 children with resistant esophageal strictures. Upper GI endoscopy was performed up to the area of stricture, esophageal dilatation was done, endoscopy was repeated, and Mitomycin C was applied topically under direct endoscopic vision. The effect of the procedure was followed over a period of 3-5 years. Results: The response to Mitomycin C was excellent (clinically and endoscopically) in 28 patients (93.3%) and good (endoscopically only) in 2 patients (6.7%). No side effects of topical Mitomycin C in children with esophageal strictures were reported in this study. Conclusion: Esophageal dilatation followed by local Mitomycin C application may be a useful strategy for treating resistant esophageal strictures.

• Archives of Plastic Surgery
• /
• 제37권4호
• /
• pp.329-334
• /
• 2010

Purpose: Adhesion after flexor tendon injury is a result of fibrosis between tendon and tendon sheath. This, finally interfere with gliding mechanism of tendon and results in functional problem of hands. Therefore, there have been many trials to reduce adhesion around the tendon. However, there is no standard procedure clinically practiced in hospitals. Mitomycin-C is an antineoplastic alkylating agent that decrease fibroblast proliferation and scar formation. It is commonly used in many surgery to reduce postoperative adhesion. This study was designed to observe the effect of Mitomycin-C on preventing adhesion in injured flexor tendon. Methods: The deep flexor tendon of digit 2 and 4 in the left forepaw of 15 New Zealand White rabbits were subjected to partial tenotomy. In study group, injury site was exposed to a single 5-minute application of Mitomycin-C, and in control group was left untreated. Digit 2 and 4 in the right forepaw of each rabbit were considered as nonadhesion control group. After 2 weeks, the animals were sacrificed and digits were amputated for biomechanical test and histological study. Results: In biomechanical study to measure yield point, mean yield point of non-adhesion control was $17.43{\pm}2.33$ and $25.07{\pm}4.03$ for adhesion control, which proves increase of adhesion in adhesion control group (p<0.05) in 95% confidence. In Mitomycin-C group, mean yield point was $12.71{\pm}4.97$. Compared with adhesion control, there was decrease in adhesiveness in Mitomycin-C group (p<0.05) in 95% confidence. In histological study, the result of adhesion control revealed massive adhesions of bony structure, fibrotic tissue and tendon structure with ablation of the border. However in Mitomycin-C group, we could find increased fibrotic tissue, but adhesion is much lesser than adhesion group and borders between structures remain intact. Conclusion: This study suggests that Mitomycin-C can significantly reduce adhesion of injured flexor tendon in rabbit model.

• 동의생리병리학회지
• /
• 제17권6호
• /
• pp.1404-1408
• /
• 2003

The combined effects of water-soluble fraction of Moschus (ME) and anti-tumor drug mitomycin C on the proliferation of human tumor cell-lines were estimated by MTT colorimetric assay. ME inhibited the proliferation of Hep G2, A540, HeLa, KHOS-NP and Balb/c 3T3 cells. Also, ME increased the cytotoxicity of mitomycin C on Hep G2, A549 and HeLa cells. In addition, ME enhanced the cell viability of murine splenocytes and human lymphocytes at the concentration of 100㎍/㎖. These results indicate that ME inhibits the proliferation of human tumor cells and increases the cytotoxicity of mitomycin C without cytoxicity on immune cells.